Sign In
Buy STIM
$1.20
-0.0300 (-2.44%)
At Close: Jun 22, 2026
STIM Stock: From $10.15 To $11.64 (14.7 Increase) Intraday Explanation
09:33am, Tuesday, 04'th May 2021
The stock price of Neuronetics Inc (NASDAQ: STIM) increased from $10.15 to a day high of $11.64 during intraday trading this morning. This is why it happened.
Neuronetics Announces Retirement of Brian Farley and Appointment of Robert Cascella as Chairman of its Board of Directors
05:15pm, Wednesday, 14'th Apr 2021
MALVERN, Pa., April 14, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve t
Neuronetics Announces Appointment of Robert Cascella to its Board of Directors
04:05pm, Thursday, 01'st Apr 2021
MALVERN, Pa., April 01, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve t
Neuronetics Announces Retirement of Gregory Harper, Vice President, R&D and Clinical
04:25pm, Thursday, 11'th Mar 2021
MALVERN, Pa., March 11, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve t
Neuronetics, Inc. (STIM) CEO Keith Sullivan on Q4 2020 Results - Earnings Call Transcript
12:47pm, Tuesday, 02'nd Mar 2021
Neuronetics, Inc. (STIM) CEO Keith Sullivan on Q4 2020 Results - Earnings Call Transcript
Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates
09:51am, Tuesday, 02'nd Mar 2021
Neuronetics (STIM) delivered earnings and revenue surprises of 24.00% and 2.46%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Neuronetics Reports Fourth Quarter and Full Year 2020 Financial and Operating Results
07:30am, Tuesday, 02'nd Mar 2021
MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve th
Neuronetics (STIM) Soars 6.5%: Is Further Upside Left in the Stock?
06:04am, Tuesday, 02'nd Mar 2021
Neuronetics (STIM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the
Neuronetics to Report Fourth Quarter and Fiscal Year 2020 Financial and Operating Results and Host Conference Call
07:00am, Tuesday, 16'th Feb 2021
MALVERN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve th
Neuronetics Announces Pricing of $75 Million Public Offering of Common Stock
10:30pm, Thursday, 28'th Jan 2021
MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a commercial stage medical technology company focused on designing, developing and marketing produ
Neuronetics Announces Proposed Public Offering of Common Stock
04:01pm, Thursday, 28'th Jan 2021
MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a commercial stage medical technology company focused on designing, developing and marketing produ
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial Results
04:05pm, Tuesday, 12'th Jan 2021
MALVERN, Pa., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the
Neuronetics (STIM) in Focus: Stock Moves 6.8% Higher
01:32pm, Monday, 11'th Jan 2021
Neuronetics (STIM) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Neuronetics to Participate at the 23rd Annual ICR Westwicke Conference
04:30pm, Thursday, 07'th Jan 2021
MALVERN, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve th
Neuronetics Announces the Amendment of Credit Facility with Solar Capital Partners
04:05pm, Tuesday, 08'th Dec 2020
Amendment provides Neuronetics with available and flexible funding options through 2022 Amendment provides Neuronetics with available and flexible funding options through 2022
